Boston Common Asset Management LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 20.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 57,525 shares of the company's stock after purchasing an additional 9,870 shares during the period. Boston Common Asset Management LLC's holdings in GE HealthCare Technologies were worth $4,643,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Independence Bank of Kentucky boosted its holdings in shares of GE HealthCare Technologies by 6.0% during the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock worth $158,000 after purchasing an additional 114 shares during the last quarter. Haverford Trust Co boosted its holdings in shares of GE HealthCare Technologies by 2.4% during the 4th quarter. Haverford Trust Co now owns 4,896 shares of the company's stock worth $383,000 after purchasing an additional 115 shares during the last quarter. Tandem Capital Management Corp ADV boosted its holdings in shares of GE HealthCare Technologies by 0.4% during the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock worth $2,205,000 after purchasing an additional 118 shares during the last quarter. Arcus Capital Partners LLC boosted its holdings in shares of GE HealthCare Technologies by 3.0% during the 4th quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock worth $322,000 after purchasing an additional 119 shares during the last quarter. Finally, Custom Index Systems LLC lifted its holdings in GE HealthCare Technologies by 4.4% in the fourth quarter. Custom Index Systems LLC now owns 2,843 shares of the company's stock valued at $222,000 after acquiring an additional 120 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.
GE HealthCare Technologies Trading Down 2.2%
NASDAQ:GEHC traded down $1.57 during trading hours on Friday, reaching $69.96. 7,095,456 shares of the stock were exchanged, compared to its average volume of 3,466,202. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business has a 50-day moving average of $68.96 and a two-hundred day moving average of $79.09. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a market capitalization of $32.03 billion, a price-to-earnings ratio of 16.16, a PEG ratio of 3.19 and a beta of 1.21.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $4.78 billion for the quarter, compared to analyst estimates of $4.66 billion. During the same quarter in the prior year, the company earned $0.90 earnings per share. The company's revenue was up 2.7% on a year-over-year basis. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies announced that its board has authorized a share repurchase program on Wednesday, April 30th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 3.1% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued.
GE HealthCare Technologies Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Friday, April 25th were given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.20%. The ex-dividend date of this dividend was Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is currently 2.95%.
Analysts Set New Price Targets
GEHC has been the topic of a number of recent analyst reports. The Goldman Sachs Group decreased their price objective on GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. BTIG Research set a $95.00 price objective on GE HealthCare Technologies and gave the company a "buy" rating in a report on Monday, April 14th. Wells Fargo & Company decreased their price objective on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a report on Thursday, May 1st. Piper Sandler decreased their price objective on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Finally, UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and decreased their price objective for the company from $74.00 to $73.00 in a report on Monday, May 5th. Three research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $88.27.
Get Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories

Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.